LUNG peer analysis
Pulmonx (LUNG) against its competitors: price, today's move, 1-year return and market value side by side.
- LUNG's peers: ACRV (Acrivon Therapeutics), HYPR (Hyperfine), IMUX (Immunic), PMVP (PMV Pharmaceuticals), RLMD (Relmada Therapeutics), TCRX (TScan Therapeutics), TELA (TELA Bio).
LUNG and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| ACRV Acrivon Therapeutics | $1.40 | -10.26% | -40.68% | $60.08M |
| HYPR Hyperfine | $0.52 | -3.82% | -51.02% | $55.66M |
| IMUX Immunic | $7.03 | -4.87% | -1.44% | $111.64M |
| PMVP PMV Pharmaceuticals | $1.31 | 7.38% | -3.68% | $98.95M |
| RLMD Relmada Therapeutics | $2.62 | -15.76% | -37.32% | $279.53M |
| TCRX TScan Therapeutics | $0.14 | -3.84% | -86.15% | $9.67M |
| TELA TELA Bio | $0.73 | -6.83% | -32.70% | $32.84M |
| LUNG Pulmonx | $2.65 | -3.28% | 92.03% | $115.41M |